“ The FDA instituted its Accelerated Approval Program to allow for earlier approval of drugs that treat serious conditions, and fill an unmet medical need based on a surrogate endpoint”
The Efti/Keytruda combo ,approximately 8x the Keytruda mono results in head and neck cancer.With 5 complete responses in a extremely difficult to treat indication,with limited options.
Tumour shrinkage is considered to be a surrogate end point.
- Forums
- ASX - By Stock
- IMM
- Overnight Market report
Overnight Market report, page-1488
-
- There are more pages in this discussion • 1,344 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
(20min delay)
|
|||||
Last
29.5¢ |
Change
-0.045(13.2%) |
Mkt cap ! $428.5M |
Open | High | Low | Value | Volume |
33.0¢ | 33.0¢ | 29.5¢ | $1.468M | 4.740M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 37350 | 29.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
30.0¢ | 79295 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3000 | 0.300 |
3 | 8495 | 0.295 |
14 | 412326 | 0.290 |
9 | 268551 | 0.285 |
23 | 1308346 | 0.280 |
Price($) | Vol. | No. |
---|---|---|
0.265 | 778 | 1 |
0.280 | 7000 | 1 |
0.300 | 29280 | 1 |
0.310 | 50000 | 2 |
0.315 | 32258 | 1 |
Last trade - 16.10pm 05/08/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |